

Edge Therapeutics, a biotechnology company, transforms FDA-approved drugs into therapies that address unmet acute neurological conditions. Among its major competitors, Edge Therapeutics is ranked in 5th place for NPS while Biogen is 1st, and Athersys is 2nd.Their current market cap is $15.87M